Science ❯ Biotechnology

Therapeutics

Cancer Treatment Monoclonal Antibodies Gene Therapy AI in Drug Development Antibody Design Protein Engineering Clinical Trials Autoimmune Diseases Antibody Therapeutics Regenerative Medicine Superkines Cancer Research mRNA Technologies Chemical Research Preclinical Testing Drug Delivery Cellular Therapies Early Stage Companies Immunology Antibody Engineering Cancer Therapies Molecular Biology Advanced Therapies

Boxer Capital Buys 1.24 Million Vir Biotechnology Shares

The buy underscores improving sentiment, with promising trial data plus a pending Astellas payment bolstering the case.

Cyclerion to Merge With Korsana in Reverse Takeover Backed by $380 Million

Vertex’s IgA Nephropathy Drug Hits Phase 3 Goals, FDA Filing Slated for March

Bristol Myers, Janux Strike Exclusive Deal on Tumor-Activated T-Cell Engager

FDA Setback Puts uniQure’s Huntington’s Gene Therapy Filing in Doubt

Novartis Licenses Arrowhead’s RNAi Parkinson’s Drug in Deal Worth Up to $2.2 Billion

Frazier Life Sciences Closes $1.3 Billion Early-Stage Biotech Fund